Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome

Abstract Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that impairs glucose transport across the blood–brain barrier resulting in hypoglycorrhachia and decreased fuel for brain metabolism. Neuroglycopenia causes a drug‐resistant metabolic epilepsy due to energy deficie...

Full description

Saved in:
Bibliographic Details
Main Authors: Santhi N. Logel, Ellen L. Connor, David A. Hsu, Rachel J. Fenske, Neil J. Paloian, Darryl C. De Vivo
Format: article
Language:EN
Published: Wiley 2021
Subjects:
Online Access:https://doaj.org/article/1006b62dddf24bd2aac90a7b32bca90a
Tags: Add Tag
No Tags, Be the first to tag this record!